| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/11/2009 | EP2032594A1 Glycyrrhetinic acid derivatives |
| 03/11/2009 | EP2032585A2 Substituted pteridines as therapeutic agents |
| 03/11/2009 | EP2032584A2 Thiadiazole compounds and methods of use thereof |
| 03/11/2009 | EP2032583A1 New chemical compounds |
| 03/11/2009 | EP2032581A2 Polymorphic forms and process |
| 03/11/2009 | EP2032578A2 Triazolopyridazine derivatives |
| 03/11/2009 | EP2032573A1 Substituted arylpyrazolopyridines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 03/11/2009 | EP2032572A1 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them |
| 03/11/2009 | EP2032562A2 Selective inhibitors of rock protein kinase and uses thereof |
| 03/11/2009 | EP2032560A1 Substituted bicyclic and tricyclic thrombin receptor antagonists |
| 03/11/2009 | EP2032559A1 2-heterocycloamino-4-imidazolylpyrimidines as agents for the inhibition of cell proliferation |
| 03/11/2009 | EP2032544A1 Crystalline forms of letrozole and processes for making them |
| 03/11/2009 | EP2032535A1 Spirocyclic nitriles as protease inhibitors |
| 03/11/2009 | EP2032531A1 Salts of n-hydroxy-3-[4-[[[2-(2-methyl-1h-indol-3-yl)ethyl]amino]methyl]phenyl]-2e-2-propenamide |
| 03/11/2009 | EP2032172A2 Leptomycin derivatives |
| 03/11/2009 | EP2032168A1 Capecitabine combination therapy |
| 03/11/2009 | EP2032165A1 Bioactive purified hspe7 compositions |
| 03/11/2009 | EP2032159A2 Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof |
| 03/11/2009 | EP2032153A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma |
| 03/11/2009 | EP2032152A1 Use cathelicidin antimicrobial protein (hcap18 ) as anticancer agent |
| 03/11/2009 | EP2032141A1 Inhibitors of janus kinases |
| 03/11/2009 | EP2032140A1 Pyrrolo[1,2-a]pyrazin-1(2h)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2h)-one derivatives as inhibitors of poly(adp-ribose)polymerase(parp) |
| 03/11/2009 | EP1843759B1 Therapeutic extracts obtained from calomeria amarnthoides and their uses |
| 03/11/2009 | EP1789416B1 Amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents |
| 03/11/2009 | EP1691824B1 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 03/11/2009 | EP1656129A4 Blockade of mtor to prevent a hormonal adaptive response |
| 03/11/2009 | EP1485364B1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
| 03/11/2009 | EP1480984B9 Hexacyclic compounds |
| 03/11/2009 | EP1468085B1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 03/11/2009 | EP1456182B1 Pyrimidine derivatives as modulators of insuline-like growth factor-1 receptor (igf-i) |
| 03/11/2009 | EP1349840B1 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 03/11/2009 | EP1302476B1 Reduced fk228 and use thereof |
| 03/11/2009 | EP1294384B1 Use of lanthanum compounds for the treatment of bone diseases |
| 03/11/2009 | EP1268799B1 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 03/11/2009 | EP0977579B1 Gastrin receptor-avid peptide conjugates |
| 03/11/2009 | CN101384716A Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 03/11/2009 | CN101384622A FGF2-binding peptides and uses thereof |
| 03/11/2009 | CN101384600A Crystalline forms of (3r,4r)-4-amino-1-[[4-[(3-methoxyphenyl)amino]pyrrolo[2,1-f][1,2,4]triazin-5-yl]methol]piperidin-3-ol |
| 03/11/2009 | CN101384586A Pi-3 kinase inhibitors and methods of their use |
| 03/11/2009 | CN101384577A Novel coumarin derivative having antitumor activity |
| 03/11/2009 | CN101384566A Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as sip receptor agonists |
| 03/11/2009 | CN101384277A Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same |
| 03/11/2009 | CN101384275A Dissolution aids for oral peptide delivery comprising a biguanide |
| 03/11/2009 | CN101384267A Ibandronate regimen for treating metastatic bone pain |
| 03/11/2009 | CN101384264A Therapeutic combinations comprising poly (adp-ribose) polymerases inhibitor |
| 03/11/2009 | CN101381776A Method for detecting PPN/MG61 expression and use thereof |
| 03/11/2009 | CN101381742A Late promoter targeting regulation oncolytic adenovirus pCN305 vector and construction method and application thereof |
| 03/11/2009 | CN101381728A Human interferon alpha-2b recombinant bacillus calmette-guerin, construction method and identification method thereof |
| 03/11/2009 | CN101381725A Circular dumbbell decoy oligodeoxynucleotide (CDODN) containing transcription DNA binding sites |
| 03/11/2009 | CN101381414A Ovarian cancer anti-idiotype antibody and preparation of heat shock protein fusion protein and application |
| 03/11/2009 | CN101381413A Modified recombinant human endostatin and use thereof |
| 03/11/2009 | CN101381409A N-terminally chemically modified protein compositions and methods |
| 03/11/2009 | CN101381405A Genetic engineering tumor targeting KCT-W1 polypeptides and preparation method and application |
| 03/11/2009 | CN101381404A Targeting tumor protein KCT-W2, preparation method and application |
| 03/11/2009 | CN101381402A NY-ESO-1 tumour antigen mimic epitope and use thereof |
| 03/11/2009 | CN101381396A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381395A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381394A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381393A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381392A Pentacyclic triterpene saponins compounds, preparation method and use |
| 03/11/2009 | CN101381391A Triterpene saponins compounds extracted from ardipusilloside |
| 03/11/2009 | CN101381380A Platinum (II) complexes and antineoplastic activity thereof |
| 03/11/2009 | CN101381374A Pyrazinetin dicarboxylate coordination compound, preparation method thereof and use |
| 03/11/2009 | CN101381373A Trimethyl tin coordination compound, preparation method thereof and use |
| 03/11/2009 | CN101381371A Dithiolopyrrolones compounds and preparation method and application thereof |
| 03/11/2009 | CN101381348A Thiazolidone derivates and application thereof in preparing anti-lung cancer medicine |
| 03/11/2009 | CN101381320A Compounds with mannich base structure and application thereof in preparation of medicament treating and/or preventing |
| 03/11/2009 | CN101380473A Gold nano-bar based medicine carrier and preparation technique and use thereof |
| 03/11/2009 | CN101380465A Construction method of Beta-alexin-2-tumor vaccine and uses thereof |
| 03/11/2009 | CN101380463A Composition and its therapeutic use |
| 03/11/2009 | CN101380404A Traditional Chinese medicine for treating metrocarcinoma |
| 03/11/2009 | CN101380350A Chinese caterpillar fungus heart-resurrection compound capasules |
| 03/11/2009 | CN101380346A Traditional Chinese composition for treating tumor and production method thereof |
| 03/11/2009 | CN101380340A Wall-broken glossy ganoderma spore powder antioxidation method |
| 03/11/2009 | CN101380327A Anti-cancer composite sustained-release composition and preparation method thereof |
| 03/11/2009 | CN101380325A Composition of artemisinin derivative and vinorelbine, and use thereof |
| 03/11/2009 | CN101380310A Composition of bFGF modified liposome and shRNA expression vector targeting human VEGF gene and preparation method thereof |
| 03/11/2009 | CN101380308A Anticancer sustained-release preparation loaded with anti-cancer medicine and synergist thereof |
| 03/11/2009 | CN101380307A Anticancer sustained-release formulation loaded with anti-cancer medicine and synergist thereof |
| 03/11/2009 | CN101380306A Compound platinum medicine sustained-release agent |
| 03/11/2009 | CN101380305A Anticancer sustained-released formulation loaded with blood vessel inhibitor and synergist thereof |
| 03/11/2009 | CN101380304A Anticancer sustained-released formulation loaded with blood vessel inhibitor and synergist thereof |
| 03/11/2009 | CN101380303A Anti-cancer medicine sustained-released injection loaded with platinum compound and synergist thereof |
| 03/11/2009 | CN101380299A Sustained-release injection containing methotrexate and synergist thereof |
| 03/11/2009 | CN101380298A Methotrexate sustained-release injection |
| 03/11/2009 | CN101380297A Compound platinum medicine sustained-release agent |
| 03/11/2009 | CN101380296A Anticancer sustained-release formulation loaded with platinum compound and synergist thereof |
| 03/11/2009 | CN101380295A Anti-cancer medicine sustained-release injection loaded with platinum compound and synergist thereof |
| 03/11/2009 | CN101380292A Sustained-released injection and preparation method and use thereof |
| 03/11/2009 | CN101380291A Sustained-release injection and preparation method thereof |
| 03/11/2009 | CN101380097A Cancer prevention health-care noodles and production method thereof |
| 03/11/2009 | CN100467603C DNA sequences coding for the human proteins TX and TY related to the interleukin-IBeta converting enzyme |
| 03/11/2009 | CN100467494C Organic medicine and betacyclodextrin derivative and preparation process thereof |
| 03/11/2009 | CN100467490C Solid phase synthesis method of peptide-spacer-lipoid conjugate, synthesized conjugate and targeting liposome containing the conjugate |
| 03/11/2009 | CN100467488C Il-7 fusion proteins |
| 03/11/2009 | CN100467482C New antitumoral compounds |
| 03/11/2009 | CN100467476C Derivatives of branched-chain lipophilic molecules and uses thereof |
| 03/11/2009 | CN100467469C A2b adenosine receptor antagonists |
| 03/11/2009 | CN100467461C N-oxyde of N-phenyl-2-pyrimidine-amine derivatives |
| 03/11/2009 | CN100467450C Anthranilic acid amides and pharmaceutical use thereof |